Heartflow, Inc. (NASDAQ:HTFL) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Posted by George Bondi on Sep 19th, 2026

Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twelve analysts that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, eight have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among brokers that have covered the stock in the last year is $44.8750.

A number of research firms recently commented on HTFL. Benchmark reissued a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. UBS Group assumed coverage on Heartflow in a research report on Wednesday, September 9th. They set a “neutral” rating and a $55.00 price target on the stock. Canaccord Genuity Group increased their price objective on Heartflow from $37.00 to $45.00 and gave the company a “buy” rating in a report on Friday, August 14th. Piper Sandler restated an “overweight” rating and set a $45.00 price target (up from $38.00) on shares of Heartflow in a research note on Friday, August 14th. Finally, Robert W. Baird set a $45.00 price target on shares of Heartflow in a report on Friday, August 14th.

View Our Latest Report on HTFL

Heartflow Price Performance

HTFL opened at $50.75 on Friday. The firm has a market capitalization of $4.41 billion and a PE ratio of -27.73. The business’s 50-day moving average is $37.75 and its two-hundred day moving average is $31.70. Heartflow has a 1 year low of $20.13 and a 1 year high of $52.22.

Heartflow (NASDAQ:HTFL – Get Free Report) last released its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business had revenue of $64.08 million for the quarter. The business’s quarterly revenue was up 47.7% on a year-over-year basis. As a group, sell-side analysts expect that Heartflow will post -0.75 EPS for the current year.

Insider Activity

In other Heartflow news, CFO Vikram Verghese sold 16,766 shares of Heartflow stock in a transaction that occurred on Friday, September 18th. The shares were sold at an average price of $50.75, for a total transaction of $850,874.50. Following the completion of the sale, the chief financial officer directly owned 155,183 shares in the company, valued at approximately $7,875,537.25. The trade was a 9.75% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John Farquhar sold 3,890 shares of the company’s stock in a transaction on Friday, September 11th. The shares were sold at an average price of $50.00, for a total transaction of $194,500.00. Following the completion of the sale, the chief executive officer directly owned 321,914 shares in the company, valued at approximately $16,095,700. The trade was a 1.19% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 306,985 shares of company stock worth $13,246,070. Company insiders own 7.70% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of HTFL. XXEC Inc. acquired a new stake in Heartflow during the second quarter valued at $2,524,764,000. BlackRock Inc. acquired a new position in shares of Heartflow in the second quarter worth about $152,502,000. Bamco Inc. NY purchased a new stake in shares of Heartflow during the 2nd quarter worth about $94,625,000. Jupiter Topco LLC acquired a new stake in shares of Heartflow during the 2nd quarter valued at about $70,983,000. Finally, Janus Henderson Group PLC grew its position in shares of Heartflow by 152.0% during the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock valued at $53,063,000 after acquiring an additional 1,315,416 shares during the period.

About Heartflow

(Get Free Report)

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries.

The company’s primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).